Collegium Pharmaceutical, Inc.
Hedge Funds Holdings
Last updated:
Collegium Pharmaceutical, Inc.‘s stocks are currently a part of 131 hedge funds’ portfolios, which represents 70% of the total amount of its stocks outstanding. This makes up a total of 23.50M shares of Collegium Pharmaceutical, Inc.. Compared to the previous quarter, the number fell by -34.88% or -12.59M shares fewer. As for the holding position changes, 32.06% (42) of current hedge fund investors increased the number of shares held, 31.3% (41) of current holders sold a part of the shares held, and 12.21% (16) closed the holdings completely. 31 hedge funds are new holders of Collegium Pharmaceutical, Inc. stock in Q1 2023, it is 23.66% of total holders.
Hedge funds holding Collegium Pharmaceutical (Q2 2018 – Q1 2023)
| Q2 2018 | 132 |
|---|---|
| Q3 2018 | 123 |
| Q4 2018 | 120 |
| Q1 2019 | 144 |
| Q2 2019 | 128 |
| Q3 2019 | 116 |
| Q4 2019 | 136 |
| Q1 2020 | 158 |
| Q2 2020 | 149 |
| Q3 2020 | 139 |
| Q4 2020 | 137 |
| Q1 2021 | 162 |
| Q2 2021 | 157 |
| Q3 2021 | 152 |
| Q4 2021 | 155 |
| Q1 2022 | 166 |
| Q2 2022 | 156 |
| Q3 2022 | 162 |
| Q4 2022 | 177 |
| Q1 2023 | 131 |
Hedge funds changes in Collegium Pharmaceutical positions (Q2 2018 – Q1 2023)
| Q2 2018 | 22 | 54 | 35 | 29 | -8 |
|---|---|---|---|---|---|
| Q3 2018 | 20 | 46 | 35 | 28 | -6 |
| Q4 2018 | 17 | 40 | 49 | 19 | -5 |
| Q1 2019 | 40 | 37 | 43 | 17 | 7 |
| Q2 2019 | 24 | 52 | 32 | 37 | -17 |
| Q3 2019 | 17 | 39 | 32 | 27 | 1 |
| Q4 2019 | 42 | 40 | 39 | 22 | -7 |
| Q1 2020 | 43 | 48 | 50 | 20 | -3 |
| Q2 2020 | 17 | 61 | 54 | 26 | -9 |
| Q3 2020 | 14 | 40 | 59 | 22 | 4 |
| Q4 2020 | 20 | 40 | 54 | 23 | 0 |
| Q1 2021 | 38 | 50 | 54 | 13 | 7 |
| Q2 2021 | 16 | 61 | 43 | 19 | 18 |
| Q3 2021 | 21 | 50 | 54 | 27 | 0 |
| Q4 2021 | 22 | 50 | 57 | 18 | 8 |
| Q1 2022 | 27 | 61 | 54 | 14 | 10 |
| Q2 2022 | 18 | 52 | 66 | 22 | -2 |
| Q3 2022 | 26 | 56 | 48 | 22 | 10 |
| Q4 2022 | 28 | 51 | 70 | 10 | 18 |
| Q1 2023 | 31 | 42 | 41 | 16 | 1 |
Hedge funds changes in Collegium Pharmaceutical stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 1,275,000 | 2,460,000 |
|---|---|---|
| Q3 2018 | 6,120,000 | 948,000 |
| Q4 2018 | 1,195,000 | 319,000 |
| Q1 2019 | 395,000 | 197,000 |
| Q2 2019 | 1,155,000 | 735,000 |
| Q3 2019 | 191,000 | 248,000 |
| Q4 2019 | 1,263,000 | 237,000 |
| Q1 2020 | 1,472,000 | 1,190,000 |
| Q2 2020 | 2,535,000 | 579,000 |
| Q3 2020 | 1,740,000 | 537,000 |
| Q4 2020 | 1,846,000 | 1,699,000 |
| Q1 2021 | 2,419,000 | 1,432,000 |
| Q2 2021 | 2,000 | 16,000 |
| Q3 2021 | 312,000 | 11,000 |
| Q4 2021 | 18,000 | 1,000 |
| Q1 2022 | 719,000 | 497,000 |
| Q2 2022 | 628,000 | 197,000 |
| Q3 2022 | 1,337,000 | 16,000 |
| Q4 2022 | 2,088,000 | 32,480 |
| Q1 2023 | 2,399,000 | 1,548,043,000 |